Description
Description
Tirzepatide (45mg) is a dual GIP and GLP-1 receptor agonist utilized in advanced metabolic research. This high-concentration formulation is ideal for studying chronic dual-pathway activation and its effects on energy homeostasis.
Research Applications
Investigations focus on the synergistic biological responses of dual incretin receptor targeting in experimental models.
Reviews
There are no reviews yet.